Rankings
▼
Calendar
IMUX Q1 2019 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena
IMUX
Immunic, Inc.
$138M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$9M
EPS (Diluted)
$-11.21
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$10M
Total Liabilities
$1M
Stockholders' Equity
$9M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$10M
-$14M
+34.1%
Net Income
-$9M
-$14M
+34.0%
← FY 2019
All Quarters
Q2 2019 →